Advertisement
Advertisement

MGX

MGX logo

Metagenomi Inc.

3.13
USD
-0.265
-7.82%
Dec 18, 15:59 UTC -5
Closed
...

Metagenomi Inc. Profile

About

Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.

Info & Links

CEO

Brian C. Thomas

Headquarters

5959 HORTON STREET, 7TH FLOOR
EMERYVILLE, CA 94608, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

282

Employees

236

Metagenomi Inc. Statistics

Valuation Measures

Market Capitalization2

116.94M

Enterprise Value

91.82M

Enterprise Value/EBITDA(ttm)

-1.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.20

Price to Book(mrq)

0.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-130.54%

Profit Margin(ttm)

-149.42%

Return on Equity(ttm)

-43.23%

Return on Invested Capital(ttm)

-29.42%

Return on Assets(ttm)

-18.86%

Income Statement

Revenue(ttm)

55.08M

Revenue Per Share(ttm)

1.47

Gross Profit(ttm)

55.08M

EBITDA(ttm)3

-91.48M

Net Income Available to Common(ttm)

-73.95M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

37.42M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

274.59M

Total Cash Per Share(mrq)

7.34

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.18%

Quick Ratio(mrq)

6.18%

Book Value Per Share(mrq)

6.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.25

Free Cash Flow(ytd)

-85.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement